GSK-3β: a key regulator of breast cancer drug resistance.

Martelli, Alberto M

GSK-3β: a key regulator of breast cancer drug resistance. [electronic resource] - Cell cycle (Georgetown, Tex.) 2014 - 697-8 p. digital

Publication Type: Journal Article; Comment

1551-4005

10.4161/cc.28091 doi


Antibiotics, Antineoplastic--pharmacology
Antineoplastic Agents, Hormonal--pharmacology
Doxorubicin--pharmacology
Drug Resistance, Neoplasm
Female
Glycogen Synthase Kinase 3--antagonists & inhibitors
Glycogen Synthase Kinase 3 beta
Humans
Tamoxifen--pharmacology